Advertisement
Commenting on this achievement, Edward Wright, CEO of CRH MedicalCorporation stated, "In 2007, we demonstrated the strong demand for the CRHO'Regan hemorrhoid banding technology and treatment protocol. In 2008, we planto open several additional Centers in new markets throughout the United Statesallowing CRH to further capitalize on this large and underserved market.According to the National Institutes of Health the prevalence rate ofsymptomatic hemorrhoids in the United States is approximately 4.4% of thepopulation or 13.3 million people."
Advertisement
Centers open one year or longer continue to show strong growth, withpatient visits increasing 485% for the three months ended December 31, 2007compared to the same period in 2006.
Commenting on the CRH O'Regan Hemorrhoid Banding technology and treatmentprotocol, Dr. Iain Cleator, Chief Medical Director of CRH said, "The mostimportant aspect of our technology and treatment protocol is that we areexperiencing the same excellent results in each of our Centers. This meansthat our training methodology and treatment protocol is transferable andreproducible."
Dr. Carolyn Million, Medical Director of CRH's San Francisco Center,added, "As a Fellow of the American Society of Colon and Rectal Surgeons Ihave treated hemorrhoids for 15 years. In my opinion the CRH O'Regan bandingtechnology and treatment protocol consistently provide a significantly higherlevel of patient satisfaction compared with other hemorrhoid treatmentsoptions."
About CRH Medical Corporation:
CRH Medical Corporation is utilizing the first single use, patented,disposable, hemorrhoid banding system through its Center for Colorectal Healthfacilities. According to the National Institute of Health approximately 50% ofthe U.S. population will develop hemorrhoids by age 50. CRH Medical is openingits Center for Colorectal Health facilities in the United States specializingin the treatment of hemorrhoids and fissures, and colon cancer screening andplans to significantly increase the number of Centers for Colorectal Healthacross the U.S. to address this underserved market. The Company's goal is tobecome the preeminent resource on colorectal health for consumers and medicalprofessionals in North America.
The information in this news release contains so-called "forward-looking"statements. These include statements regarding CRH Medical expectations,beliefs, intentions or strategies for the future, which may be indicated bywords or phrases such as "anticipate", "expect", "intend", "plan", "will", "webelieve", "CRH Medical believes", "management believes" and similar language.All forward-looking statements are based on CRH Medical current expectationsand are subject to risks and uncertainties and to assumptions made.
CONTACT: Dean Linden, Investor Relations, CRH Medical Corporation at (604)633-1440, or [email protected]; Additional information may also be found byvisiting the Company's website at www.crhmedcorp.com, or the SEDAR website atwww.sedar.comThe TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.
SOURCE CRH Medical Corporation
